Analysts Are Increasing Price Targets of These 5 Stocks

04. HCA Healthcare, Inc. (NYSE:HCA)

Number of Hedge Fund Holders: 64

On April 25, Wells Fargo analyst Stephen Baxter raised the price target on HCA Healthcare, Inc. (NYSE:HCA) from $243 to $275 and maintained an Equal Weight rating on the shares. The firm notes that HCA Healthcare, Inc. (NYSE:HCA) results were generally strong, and the company seems to be positioned for attractive EBITDA growth in 2024 and 2025.

Renaissance Large Cap Growth Strategy made the following comment about HCA Healthcare, Inc. (NYSE:HCA) in its Q4 2022 investor letter:

“Lastly, HCA Healthcare, Inc. (NYSE:HCA) was another contributor. The company is seeing solid improvements in surgical volumes and overall healthcare usage. Meanwhile, labor expenses, which have weighed heavily on operating margins, appear to be reversing as extra headcount brought on to accommodate spikes in patient volumes due to COVID is finally subsiding.”